Method to determine the concentration of anticoagulants
AssigneeDade International Inc.
InventorsHendrick Coenraad Hemker, Robert Johan Wagenvoord, Hans-Jurgen Kolde
Life of this patent
Estimating the term…
Loading patent…
AssigneeDade International Inc.
InventorsHendrick Coenraad Hemker, Robert Johan Wagenvoord, Hans-Jurgen Kolde
Estimating the term…
The present invention relates to a method to determine the concentration of anticoagulants as a function of the inhibition of thrombin formation in an assay mixture. The assay mixture is composed of two reagents and the diluted plasma sample. The diluted plasma sample containing an anticoagulatory substance is mixed with a clotting factor reagent, which is a combination of an excess amount of purified coagulation factors of the endogenous system, phospholipids and a weak thrombin inhibitor, which can be potentiated by an anticoagulatory substance. Then a coagulation cascade activator and calcium chloride, an activator reagent, is added to the mixture and formed thrombin is measured after a chosen incubation time. A proportionality between the inhibition of the thrombin formation and the anticoagulatory active components allows for a determination of the concentration of anticoagulatory active components in the sample.
A method to determine a concentration of an anticoagulant in a sample as a function of thrombin formation in said sample comprising:
A method to determine a presence or concentration of an anti-coagulant in a sample, the method comprising:
A kit to determine a concentration of an anticoagulant in a sample comprising:
A kit to determine a concentration of an anticoagulant in a sample comprising:
Dependencies are inferred from the claim text.